Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
07/2012
07/11/2012EP2415870A9 Rnai molecule for thymidylate synthase and use thereof
07/11/2012CN102575283A Diagnosis and treatment of cell proliferation and differentiation disorders based on the FMN 2 gene
07/11/2012CN102575254A Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA
07/11/2012CN102575251A Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
07/11/2012CN102575250A Treatment and diagnosis of immune disorders
07/11/2012CN102575232A Simian adenovirus 41 and uses thereof
07/11/2012CN102573924A Drug composition for angiogenesis therapy
07/11/2012CN102573897A Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector
07/11/2012CN102573799A Pharmaceutical composition containing medicament-containing fine particles and method for producing same
07/11/2012CN102573797A Emulsion activatable by ultrasounds and method for producing same
07/11/2012CN102559895A Application of human Nin one binding (NOB1) gene and related medicine
07/11/2012CN102559761A Method for regulating development of embryonic liver cells by SNX7 gene and application of SNX7 gene
07/11/2012CN102559759A HIP/PAP recombinant adenovirus and application thereof in resisting ulcerative colitis
07/11/2012CN102559753A IL-24 and OSM double-gene co-expression recombinant plasmid, recombinant adenovirus and application
07/11/2012CN102559687A Spindle centromere associated protein Z (CENP-Z) and encoded gene as well as application thereof
07/11/2012CN102559609A Recombined adenovirus vaccine for preventing AIDS
07/11/2012CN102558569A Lipopolysaccharide amine cationic polymer and preparation method and application thereof
07/11/2012CN102558565A Polyethylene glycol monomethyl ether-polycaprolactone-polyphosphate copolymer and application thereof
07/11/2012CN102558363A Polypeptide carrier for improving medicament/gene tumor targeting and transfection efficiency and application
07/11/2012CN102558358A Preparation and application of human fibroblast growth factor 21 fusion protein and mutant of human fibroblast growth factor 21 fusion protein
07/11/2012CN102558336A PRR11 gene and coded protein and application thereof
07/11/2012CN102558319A Mycobacterium tuberculosis wag31 gene and application thereof
07/11/2012CN102558270A 20(S) and 20(R)-dammarane-3beta,12beta,20,25-tetrol derivative and preparation method and application thereof
07/11/2012CN102558158A Hairpin polyamide modified by or free of beta-hydroxyl-gamma-amino acid and preparation method and application
07/11/2012CN102552987A Biological material in liquid at 4 DEG C and solid at 37 DEG C and preparation method and application
07/11/2012CN102552947A Cation microvesicle and preparation method thereof
07/11/2012CN102552938A Application of Egr-1 antagonist to preparation of medicine for treating type II diabetes
07/11/2012CN102552937A Application of human p21-activated kinase 7 (PAK7) gene and relevant medicines of human PAK7 gene
07/11/2012CN102552936A siRNA (small-interfering RNA) vector complex for gene-targeted delivery and preparation method of the complex
07/11/2012CN102552935A Use of hepatocyte nuclear factor-1alpha in treatment of chronic liver disease
07/11/2012CN102552929A Method for enhancing targeting selectivity of administration system by modifying cell penetrating peptide
07/11/2012CN102552924A Application of neutral dendritic polymer material to preparing drug carrier
07/11/2012CN102552912A Use of adrenergic beta-3-receptor retardant in tumor resistance
07/11/2012CN102552910A Application of extracellular matrix protein 1 and regulator thereof in preparing medicament for diagnosing or treating allergic diseases
07/11/2012CN102552901A Application of fullerene derivative, as well as vaccine adjuvant and vaccine preparation thereof
07/11/2012CN102071204B Deoxyribonucleic acid (DNA) aptamer for mycobacterium tuberculosis glycolipid antigen and application thereof
07/11/2012CN101974152B Lipoid-cation polymer and preparation method thereof
07/11/2012CN101798348B Anti-uPAR humanized antibody and application thereof
07/11/2012CN101573448B Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
07/11/2012CN101126098B Small disturbance RNA molecule expression carrier for differentially inhibiting GFAP protein expression and its construction method and use thereof
07/10/2012US8217157 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
07/10/2012US8217146 Neurotrophic factors and methods of use thereof
07/10/2012US8217020 Methods and compositions for reducing viral genome amounts in a target cell
07/10/2012US8217019 AIDS virus vaccines using Sendai virus vector
07/10/2012US8217016 Application of mRNA for use as a therapeutic agent for tumorous diseases
07/10/2012US8217015 Endosomolytic polymers
07/10/2012US8216834 Chimpanzee adenovirus vaccine carriers
07/10/2012US8216819 Generation of oncolytic adenoviruses and uses thereof
07/10/2012US8216795 Tuberculosis diagnostic test
07/10/2012US8216792 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
07/10/2012US8216590 HCV fusion polypeptides
07/10/2012US8216584 Imaging, diagnosis and treatment of disease
07/10/2012US8216569 Vascular endothelial growth factor 2
07/10/2012US8216565 GP100-specific T cell receptors and related materials and methods of use
07/10/2012US8216564 Herpes simplex virus (HSV) derived amplicon defective viral genome carrying at least one toxic foreign gene and an HSV-derived mutant helper virus; antitumor and anticarcinogenic agents
07/10/2012CA2477954C Means and methods for the production of adenovirus vectors
07/10/2012CA2451603C Process for facilitating nucleic acid transfer
07/10/2012CA2446951C Polythiourea lipid derivatives
07/10/2012CA2435712C Universal carrier for targeting molecules to gb3 receptor expressing cells
07/10/2012CA2402017C Compositions and methods for the early diagnosis of ovarian cancer
07/10/2012CA2372583C Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
07/10/2012CA2368677C Intramyocardial injection of autologous bone marrow
07/10/2012CA2342040C Anaerobic bacterium as a drug for cancer gene therapy
07/10/2012CA2305816C Peptides capable of inhibiting the interaction between presenilins and the .beta.-amyloid peptide or its precursor
07/10/2012CA2222601C Plasmid for delivery of nucleic acids to cells and methods of use
07/10/2012CA2194172C Neurturin and related growth factors
07/05/2012WO2012092569A2 Compositions comprising immunostimulatory nucleic acids and related methods
07/05/2012WO2012092373A2 In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
07/05/2012WO2012092049A2 Brown adipocyte modification
07/05/2012WO2012091496A2 siRNA FOR INHIBITION OF Hif1α EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME
07/05/2012WO2012091137A1 GENE THERAPEUTIC AGENT USING TNF-α, CD40L, AND GM-CSF IN COMBINATION
07/05/2012WO2012091136A1 Expression vector, method for producing carrier using same, and use of same
07/05/2012WO2012091118A1 Therapeutic agent for ectopic pregnancy
07/05/2012WO2012090939A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells
07/05/2012WO2012090479A1 Mcm7 as a target gene for cancer therapy and diagnosis
07/05/2012WO2012090223A1 Poly(ether imine) dendrimers and uses thereof
07/05/2012WO2012089602A1 Small molecule conjugates for intracellular delivery of biologically active compounds
07/05/2012WO2012089352A1 Small molecule conjugates for intracellular delivery of nucleic acids
07/05/2012WO2012064758A3 Methods for modulating factor 12 expression
07/05/2012WO2012054723A3 Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua
07/05/2012WO2012024526A3 Conjugates, particles, compositions, and related methods
07/05/2012WO2012024350A3 Anti-cancer adenoviruses
07/05/2012WO2012019184A3 Compositions and methods for detecting, diagnosing, and treating cancer
07/05/2012WO2012019168A3 Engineered nucleic acids and methods of use thereof
07/05/2012WO2012009402A3 Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
07/05/2012WO2011084366A3 Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
07/05/2012US20120172631 Phosphatidyl oligoglycerols
07/05/2012US20120172525 Compositions containing inclusion complexes
07/05/2012US20120172419 Reagents and methods for modulating cone photoreceptor activity
07/05/2012US20120172418 Aslv vector system
07/05/2012US20120172412 In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages
07/05/2012US20120172314 Klotho Protein and Related Compounds for the Treatment and Diagnosis of Cancer
07/05/2012US20120172283 Methods and compositions for targeted drug delivery
07/05/2012US20120171289 Delivery systems for bioactive agents
07/05/2012US20120171244 Mucosal boosting following parenteral priming
07/05/2012US20120171242 Modified Antibody
07/05/2012US20120171236 Immunization against chlamydia pneumoniae
07/05/2012US20120171194 Method of Cell Differentiation and Uses Therefor in Screening, Diagnosis and Therapy
07/05/2012US20120171160 Expression of virus entry inhibitors and recombinant aav therefor
07/05/2012DE102010056610A1 Pharmazeutische Zusammensetzung enthaltend L-DNA A pharmaceutical composition comprising L-DNA
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 870